通过绕过E3酶向化马体 (BYETACs) 来向基酶的向降解
Tao Sun1, Shiyang Zhai1, Beate König1
1Department of Pharmaceutical and Cell Biological Chemistry, Pharmaceutical Institute, University of Bonn, 53121 Bonn, Germany.
ACS medicinal chemistry letters
|June 18, 2025
概括
研究人员开发了新的绕过E3的向嵌合体 (BYETACs) 来降解基因素脱乙酶 (HDACs). 这种新方法绕过了E3链酶,使得多发性骨髓瘤等特定细胞的向蛋白质降解成为可能.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 向蛋白质降解 (TPD) 是一个有前途的治疗策略.
- 目前的TPD方法依赖于E3结合酶,限制了它们的应用.
- 基因组脱乙酶 (HDACs) 是各种疾病的关键点.
研究的目的:
- 为TPD开发一种新型的异性双功能分子类别,即BYETACs.
- 针对独立于E3结合酶活性的基因组脱甲基酶 (HDACs).
- 为了证明BYETACs在降低HDAC蛋白水平方面的有效性.
主要方法:
- 新型异构功能分子 (BYETACs) 的设计和合成.
- 采用一种特定于ubiquitin的蛋白酶14 (USP14) 抑制剂作为一种针对26S蛋白酶子单元RPN1.1的新型配体.
- 结合了USP14连接体与HDAC抑制剂vorinostat.
- 在多发性骨髓瘤MM.1S细胞中评估蛋白质降解.
主要成果:
- 成功开发出能够向蛋白质降解的HDAC BYETAC.
- 证明BYETACs有效降低了HDAC1蛋白水平.
- 在多发性骨髓瘤细胞中展示了HDAC1的优先降解.
结论:
- BYETACs代表了针对蛋白质降解的新方法,绕过了传统的E3酶依赖.
- 这一策略为涉及HDAC的疾病,如多发性骨髓瘤提供了新的治疗途径.
- 基于USP14抑制剂的配体为开发新的TPD药物提供了一个多功能平台.
相关概念视频
Regulated Protein Degradation
7.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.7K
Spreading of Chromatin Modifications
8.5K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.5K
Histone Modification
14.2K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
14.2K
Chromatin Immunoprecipitation- ChIP
11.3K
Chromatin immunoprecipitation, or ChIP, is an antibody-based technique used to identify sites on DNA that bind to transcription factors of interest or histone proteins. It also helps determine the type of histone modifications such as acetylation, phosphorylation, or methylation.
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
11.3K
Anaphase Promoting Complex
3.0K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.0K
Chromatin Modification in iPS Cells
1.9K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.9K


